Rare diseases have become an attractive target for pharmaceutical companies both in Australia and internationally with ...
HotCopper.com on MSN6d
Neuren set for FDA talks on trial to treat developmental genetic disordersNeuren Pharmaceuticals (ASX: NEU) has been granted the chance to talk to the U.S. Food and Drug Administration (FDA) about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback